Evrima Technologies
Evrima Technologies is an Australian clinical trial recruitment technology firm that connects participants, GPs, sponsors, CROs, and trial sites through its Evrilink, Evriquest, and Evripath platforms, providing recruitment services and management software to pharmaceutical sponsors.
- Company typePrivate
- Founded2019
- HeadquartersLeichhardt, Australia
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Evrima Technologies does
Evrima Technologies is an Australian health-technology company that builds clinical trial recruitment and management software for pharmaceutical sponsors, contract research organizations (CROs), trial sites, and general practitioners. Founded in 2019 and headquartered in Leichhardt, Australia, the company operates a multi-sided platform whose three core products — Evrilink, Evriquest, and Evripath — connect trial participants, referring clinicians, sponsors, CROs, and trial sites into a single workflow. Evrilink is a clinical trial recruitment and management platform with real-time data dashboards for sponsors and trial teams; Evriquest is a participant recruitment services platform that delivers marketing campaigns and remote clinical trial nurse support; and Evripath is a clinician-facing search tool that enables GPs to discover active trials and refer patients.
Evrima monetizes through professional-services arrangements with pharmaceutical sponsors and CROs on a project or per-study basis rather than standardized per-seat SaaS pricing. Its go-to-market combines direct enterprise sales to sponsors and CROs with self-serve participant onboarding through Evrilink and a clinician-referral channel via Evripath. Marketing relies on educational content, social media, GP outreach, and direct sponsor engagement, with the company targeting the structural recruitment problem in clinical research — 90% of Australian trials and 86% of US trials miss recruitment targets. The company has raised approximately A$2.04 million in a Sept 2022 round led by Artesian VC with BridgeLane Capital and Wavemaker Ventures, employs 11-50 staff, and maintains partnerships with University of Sydney, IQVIA, Monash University, Linear, and sponsors including Chugai Pharmaceuticals, Cyclarity Therapeutics, Feldan Bio, and Kinoxis Therapeutics.
Evrima Technologies firmographics
Firmographics- Name
- Evrima Technologies
- Legal name
- Evrima Technologies Pty. Ltd.
- Website
- https://evrima.com.au
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Evrima Technologies is an Australian clinical trial recruitment technology firm that connects participants, GPs, sponsors, CROs, and trial sites through its Evrilink, Evriquest, and Evripath platforms, providing recruitment services and management software to pharmaceutical sponsors.
- Ownership category
- akta.pro rank
Evrima Technologies industry classification
Industry- Product category
- Clinical Trial Recruitment Software
- NAICS
- Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (541690), Custom Computer Programming Services (541511)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Site & Investigator Platforms (Site Payments, Feasibility, Activation) (HLACAOAJ)
- akta.pro secondary industries
- Decentralized & Hybrid Trial Site Services (Home Health/Nursing) (HLAGACAH), Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM), eCOA/ePRO/eDiary & Patient-Facing Data Collection (HLACAOAB)
Keywords
Where Evrima Technologies is headquartered
LocationHeadquarters
- HQ city
- Leichhardt
- HQ country
- Australia
- HQ region
- Oceania
Markets served
Evrima Technologies business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- Clinical Trial Recruitment Services: Evrima provides recruitment services to sponsors and CROs, including marketing campaigns, participant recruitment, and remote clinical trial nurse support. Revenue appears to be project-based or retainer arrangements with pharmaceutical companies running clinical trials.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
Evrima Technologies product offering
Product offeringCore offering
Evrima Technologies builds and operates a suite of custom clinical trial technology products (Evrilink, Evriquest, Evripath) that connect clinical trial participants, General Practitioners, sponsors, CROs, and trial sites. The platforms support participant search and registration, GP-driven patient referrals, real-time trial data management for sponsors and CROs, and tailored recruitment services including marketing campaigns and remote clinical trial nurse support.
Product overview
Evrima Technologies offers a suite of custom-built clinical trial solutions comprising three core products. Evrilink serves as the central clinical trial recruitment platform providing real-time data dashboards for sponsors and clinical trial teams. Evripath is a clinician-facing search tool enabling GPs to discover and refer patients to active clinical trials. Evriquest provides direct recruitment services including marketing campaigns and remote clinical trial nurse support. Together, these products facilitate participant search and registration, trial recruitment, trial management, and GP referrals.
Differentiator
Problem solved
Functional benefit
Brands
- Evrilink: Clinical trial recruitment platform providing transparent and streamlined clinical trial experience with real-time data and secure dashboard for clinical trial teams and sponsors.
- Evriquest
- Evripath
Products and services
- Evrilink Clinical trial recruitment and management platform providing real-time data dashboards for sponsors and clinical trial teams, enabling transparent, streamlined management of clinical trial participants throughout the trial lifecycle.
- Evriquest Participant recruitment services platform offering solutions-based, tailored service options including marketing campaign development and implementation, and remote clinical trial nurse support to recruit the right patients at the right time.
- Evripath Intuitive, dynamic, easy-to-implement search tool for General Practitioners and healthcare professionals to discover and connect their patients with relevant active clinical trials, enabling practitioner contributions to global medical research.
Quantifiable outcome
- Reduced clinical trial recruitment timelines
Companies that use Evrima Technologies
Customer profileNamed customers2 records
Segments4 records
Ideal customer profiles3 records
Evrima Technologies technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Evrima Technologies partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered minor and core.
- University of SydneyminorResearch partnership with University of Sydney for clinical trial collaboration. Logo appears on company website indicating collaborative relationship.
- IQVIAminorCollaboration with IQVIA, a global provider of clinical trial services. Logo appears on company website indicating partnership in the clinical trial ecosystem.
- LinearminorPartnership with Linear (clinical research organization). Logo appears on company website indicating collaborative relationship in clinical trial sector.
- Monash UniversityminorResearch partnership with Monash University for clinical trial collaboration. Logo appears on company website indicating collaborative relationship.
- Chugai PharmaceuticalscoreChugai Pharmaceuticals, a Japanese pharmaceutical company headquartered in Tokyo, sponsors the Coeliac Disease (DAISY) study managed by Evrima. Evrima provides recruitment services for this Phase 2 clinical trial investigating DONQ52 treatment for active coeliac disease patients.
- Cyclarity TherapeuticscoreCyclarity Therapeutics, located in Novato, California, sponsors the Heart Health Study for Acute Coronary Syndrome/Atherosclerosis managed by Evrima. Evrima provides participant recruitment services for this clinical trial.
- Feldan Bio Inc.coreFeldan Bio Inc. sponsors the Skin Cancer (BCC) Study testing treatment FLD-103 for Basal Cell Carcinoma. Evrima provides recruitment and management services for this clinical trial.
- Kinoxis Therapeutics Pty LtdcoreKinoxis Therapeutics Pty Ltd, an Australian clinical-stage biotechnology company developing therapeutics for neurological and psychiatric disorders, sponsors the Dementia-related Agitation Study. Evrima provides recruitment services for this clinical trial.
Scale indicators2 records
Recent moves6 records
Expansion highlights4 records
Evrima Technologies competitors and assessment
Company assessmentBroad incumbents
- IQVIA: World's largest CRO and clinical trial services provider with extensive patient recruitment capabilities. IQVIA is also listed as an Evrima partner, making it both a competitor in recruitment services and a potential channel partner.
- Medidata Solutions (Dassault Systèmes): Provides the Medidata platform (Rave EDC, eCOA, CTMS) widely used in clinical trials. Competes with Evrima in the eClinical and trial informatics layer where sponsors are evaluating recruitment and data platforms.
- Veeva Systems: Life sciences cloud platform offering CTMS, eTMF, and clinical operations software. Competes with Evrima in clinical trial management and operations software sold to sponsors and CROs.
Direct peers
- Antidote Technologies: Digital patient recruitment platform connecting patients to clinical trials via a network of partner health websites and a trial-matching tool. Directly comparable to Evrima's Evrilink/Evripath in addressing recruitment delays.
- AutoCruitment: Specializes in clinical trial patient recruitment using targeted digital advertising and a pre-screening platform. Directly comparable to Evrima's Evriquest recruitment services for sponsors and CROs.
- SubjectWell: Patient recruitment marketplace for clinical trials, connecting sponsors and sites with prospective participants via consumer-facing outreach. Comparable to Evrima's patient recruitment and engagement focus.
- TrialX: Provides clinical trial patient recruitment, eCOA, and real-world data solutions for sponsors and CROs. Comparable to Evrima across both recruitment services and patient-facing data collection.
Emerging players
- Deep 6 AI: AI-driven patient matching platform that mines EHR data to identify eligible clinical trial participants at sites. Comparable to Evrima's mission of accelerating recruitment, with a different technical approach (EHR-mining vs. patient-facing).
- Castor: Cloud platform for clinical trial data capture (EDC, ePRO, eConsent) used by sponsors and CROs. Adjacent competitor that competes for the same sponsor technology budget as Evrima's Evrilink.
- Clara Health: Patient recruitment platform helping sponsors reach diverse participant populations for clinical trials. Directly comparable to Evrima's focus on diverse participant recruitment for clinical studies.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
Evrima Technologies social profiles
Digital presenceEvrima Technologies financial estimates
Financial estimateRevenue estimate
Valuation estimate
Evrima Technologies leadership team
Management profileNumber of profiles
Profiles1 record
Evrima Technologies funding detail
Funding detailFunding overview
Funding rounds1 record
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Evrima Technologies M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Evrima Technologies
What does Evrima Technologies do?
Evrima Technologies builds and operates a suite of custom clinical trial technology products (Evrilink, Evriquest, Evripath) that connect clinical trial participants, General Practitioners, sponsors, CROs, and trial sites. The platforms support participant search and registration, GP-driven patient referrals, real-time trial data management for sponsors and CROs, and tailored recruitment services including marketing campaigns and remote clinical trial nurse support.
Is Evrima Technologies a public or private company?
Evrima Technologies is a private company. It is classified as venture growth investor backed and is currently operating.
When was Evrima Technologies founded?
Evrima Technologies was founded in 2019. It employs 11 to 50 people.
Where is Evrima Technologies based?
Evrima Technologies is headquartered in Leichhardt, Australia, in the Oceania region.
How does Evrima Technologies make money?
One revenue line is on record: clinical Trial Recruitment Services.
Who are Evrima Technologies's main competitors?
Broad incumbents on record are IQVIA, Medidata Solutions (Dassault Systèmes) and Veeva Systems. Direct peers are Antidote Technologies, AutoCruitment, SubjectWell and TrialX. Emerging players are Deep 6 AI, Castor and Clara Health.
Does Evrima Technologies have an API?
No public API is recorded for Evrima Technologies.
What industry is Evrima Technologies in?
Evrima Technologies's product category is Clinical Trial Recruitment Software. Its primary akta.pro industry code is HLACAOAJ, Site & Investigator Platforms (Site Payments, Feasibility, Activation), with a secondary code of HLAGACAH, Decentralized & Hybrid Trial Site Services (Home Health/Nursing). Its NAICS code is 5417 and its SIC code is 8731.